Skip to main content
OpenTrials
Completed

NCT Number: NCT06157424

Efficacy and Safety of Combined Thread Embedding Acupuncture With Auricular Acupuncture for GERD

Gastroesophageal reflux disease (GERD) is increasingly prevalent today. Proton-pump inhibitors (PPIs) are the primary treatment, yet their effectiveness remains limited. Various acupuncture methods have shown promise in treating GERD. Among these, thread embedding acupuncture (TEA) and auricular acupuncture (AA) offer the advantage of prolonged treatment per intervention, significantly reducing healthcare visits for procedures, particularly beneficial for conditions requiring extended therapy. This has led to the widespread application of TEA and AA in GERD treatment. However, evidence supporting their effectiveness remains inconclusive. In this study, we aim to assess the efficacy and safety of combining TEA with AA for treating GERD. According to traditional medicine, treatment should be pattern-based. Thus, we will focus on patients exhibiting the Liver Qi Invading Stomach pattern, as reports indicate its prevalence among GERD patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

GERD Deglutition Disorders Digestive System Diseases Esophageal Diseases Esophageal Motility Disorders Gastroesophageal Reflux Gastrointestinal Diseases

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Medical Center HCMC - Branch no.3, University of Medicine and Pharmacy at Ho Chi Minh City

Ho Chi Minh City, 700000, Vietnam

About this study

Patients with GERD diagnosed through the GerdQ score and presenting the traditional medicine pattern of Liver Qi invading Stomach, meeting the inclusion and not the exclusion criteria, will be included in the study. Upon randomization, participants will be allocated into two groups: the control and intervention groups.

The study spans four weeks. Both groups will receive standard GERD treatment following current guidelines, which include PPIs, additional antacids as required, and lifestyle modifications. The intervention group will receive an additional combination of thread embedding acupuncture therapy (TEA) every other week and auricular acupuncture (AA) weekly.

Patients will undergo weekly follow-up examinations. Symptom assessment, quality of life evaluations using specific questionnaires, and antacid medication usage will be monitored weekly. Adverse effects (AE) related to the treatment will be documented throughout the trial.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Men or women aged from 18 to 60 Years
  • GerdQ score of eight or higher
  • Having heartburn and/or regurgitation on two days per week or more
  • Diagnosis of GERD with Liver Qi Invading Stomach Pattern

Exclusion criteria

  • Any prior endoscopy-confirmed structural diseases
  • Uncontrolled inflammatory bowel disease, chronic or genetic conditions, alcohol or drug abuse history
  • Alarming symptoms indicating gastric cancer, complicated ulcers, or serious illnesses
  • History of esophageal or gastrointestinal surgery
  • Current use of medications impacting GERD treatment or assessment
  • Recent (within two weeks) Western Medicine or Traditional Medicine treatment for GERD
  • History of hypersensitivity reactions to any components involved in the intervention
  • Pregnancy or breastfeeding
  • Current participation in any other clinical trials

Treatment and study plan

Thread embedding acupuncture

Other

Thread Embedding Acupuncture is applied at acupoints including CV-12, CV-13, ST-36, PC-6, BL-17, BL-18, BL-21 on both sides of the body every 2 weeks, totaling 2 sessions over 4 weeks of intervention.

Auricular Acupuncture

Other

Auricular acupuncture is administered using adhesive patches with small needles (0.25 x 1.3 mm) placed at acupoints TF4, AH6, CO12, CO4, CO2 once a week, totaling 4 sessions over the 4-week intervention period.

standard treatment

Other

Standard treatment, continuously administered over the 4-week intervention period, involves standard doses of proton pump inhibitors, additional antacids as needed, and lifestyle modifications.

Primary outcomes

  1. The proportion of heartburn resolution

    Time frame: Day 0 and after every week during 4-week treatment (day 0, day 7, day 14, day 21, day 28)

    Heartburn resolution is assessed through patient inquiry during each follow-up examination.

Secondary outcomes

  1. The proportion of regurgitation resolution

    Time frame: Day 0 and after every week during 4-week treatment (day 0, day 7, day 14, day 21, day 28)

    Regurgitation resolution is assessed through patient inquiry during each follow-up examination.

  2. Chang in the Gastroesophageal Reflux disease Questionnaire (GerdQ) score

    Time frame: Day 0 and after every week during 4-week treatment (day 0, day 7, day 14, day 21, day 28)

    As per GerdQ, patients were prompted to recall their symptoms and utilization of over-the-counter medications in the past week. It employs a four-point Likert scale (0-3) for scoring, resulting in a total GerdQ score range from 0 to 18. A higher score signifies a more severe condition.

  3. Chang in the Frequency Scale for the Symptoms of GERD (FSSG) score

    Time frame: Day 0 and after every two week during 4-week treatment (day 0, day 14, day 28)

    The FSSG questionnaire consists of twelve questions categorized into two domains: reflux symptoms and dysmotility symptoms. Using a 5-point Likert scale (0-4), the FSSG yields a total score range of 0 to 48. A higher score suggests a more severe or significant disease.

  4. Chang in the Gastroesophageal Reflux Disease-Health Related Quality of Life (GERD-HRQL) score

    Time frame: Day 0 and after every two week during 4-week treatment (day 0, day 14, day 28)

    The GERD-HRQL questionnaire consists of 16 questions utilizing a numerical Likert-type response. Patients assess symptom severity on an ordinal scale ranging from 0 to 5. The total score range for GERD-HRQL spans from 0 to 80, incorporating evaluations for heartburn, regurgitation, and other related aspects. A higher score reflects a more severe disease.

  5. Changes in the number of antacid packets used

    Time frame: Day 0 and after every week during 4-week treatment (day 0, day 7, day 14, day 21, day 28)

    The number of antacid packets used per week will be recorded during each follow-up visit.

  6. The proportion of side effects of thread embedding acupuncture and auricular acupuncture

    Time frame: Up to 4 weeks

Sponsors and collaborators

Lead sponsor

University of Medicine and Pharmacy at Ho Chi Minh City

Other

Registry information

Official study title

Evaluating Efficacy and Safety of Combined Thread Embedding and Auricular Acupuncture in Gastroesophageal Reflux Disease With Liver Qi Invading Stomach Pattern: A Randomized Controlled Trial

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Dec 5, 2023
Registry last updated
Mar 20, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.